Morphology and Forms of Existence
The pathogen exists in two radically different morphological forms, ensuring its survival both within the host and in the external environment.
- Vegetative form (trophozoite). Pear-shaped and flattened, measuring 12–15 by 5–9 µm. The cell contains two nuclei. The parasite uses four pairs of flagella for motility, producing a characteristic tumbling motion. It attaches to the intestinal mucosa using a specialized organelle called the adhesive disk.
- Cyst. Formed to withstand unfavorable conditions. Oval-shaped (8–12 by 7–10 µm) and protected by a thick, double-walled shell. A distinguishing feature of the mature cyst is the presence of four nuclei.
Epidemiology and Life Cycle
The primary source of infection is humans (symptomatic patients or asymptomatic cyst carriers). Animals serve as reservoirs less frequently, including dogs, cattle, and wild species (deer, beavers, muskrats). The transmission mechanism is fecal-oral.
Transmission routes include contaminated water and food, as well as unwashed hands and fomites. Outbreaks of waterborne infection are well documented. Men who have sex with men represent a specific high-risk group, with infection rates of Giardia and/or amoebae reaching up to 40%.
Life Cycle Features:
- Ingested cysts reach the upper gastrointestinal tract, where they transform into trophozoites.
- Using the adhesive disk, parasites firmly attach to enterocytes (adhering to the microvilli of the plasma membrane).
- Reproduction occurs via longitudinal binary fission.
- Reaching the lower, less favorable parts of the intestine, trophozoites encyst (form a protective shell) and are excreted in the feces.
Cysts exhibit high resilience: they remain viable in cold water and soil for over two months, tolerate low temperatures, and survive standard water chlorination.
Pathogenesis and Clinical Presentation
Massive proliferation of vegetative forms in the duodenum and jejunum leads to mechanical blockage of the mucosal surface. This disrupts membrane-bound (brush border) digestion and impairs normal intestinal motility. An immunological component also contributes to pathogenesis: T lymphocytes can damage the jejunal mucosa. Disease severity correlates directly with the host's overall immune resistance.
Clinically, giardiasis manifests as diarrhea, enterocolitis, weight loss, decreased appetite, and systemic metabolic disturbances.
Physicians identify three leading syndromes in symptomatic cases:
- Gastroenterocolitic;
- Cholecystopancreatic;
- Asthenic.
Diagnosis, Treatment, and Prevention
The infection triggers both cellular and humoral immune responses. However, laboratory confirmation is required to establish a diagnosis.
Diagnostic Methods:
- Microscopy. Considered the gold standard. Cysts are identified in formed stool samples using Lugol's iodine staining. In cases of diarrhea or in duodenal aspirates, live vegetative forms can be observed in wet mounts (a differential feature is the "falling leaf" motility of the trophozoite).
- Serology. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence assay (IFA) detect rising titers of specific antibodies.
Treatment and Prevention: Eradication of the pathogen is achieved using nitroimidazoles (metronidazole, tinidazole, ornidazole) and nitrofuran derivatives (furazolidone). Preventive measures rely on strict adherence to sanitation and hygiene rules, similar to the prevention of amebiasis.